Evaluation of availability, accessibility and prescribing pattern of medicines in the Islamic Republic of Iran

Eastern Mediterranean Health Journal

Volumn 10, Issue 3, 2004, Pages 406-415

  Cheraghali, A M ^a,b   Nikfar, S ^c   Behmanesh, Y ^c   Rahimi, V ^d   Hibibipour, F ^e   Tirdad, R ^c   Asadi, A ^c   Bahrami, A ^c  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

^c Food and Drug Organization   (Iran)

^d Food and Drug Department   (Iran)

^e Food and Drug Department   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIDIARRHEAL AGENT; ANTIPYRETIC AGENT; ANTITUSSIVE AGENT; COTRIMOXAZOLE; ORAL REHYDRATION SOLUTION; PROCAINE PENICILLIN; SPASMOLYTIC AGENT;

ARTICLE; CONTROLLED STUDY; DIARRHEA; DRUG COST; DRUG MONITORING; DRUG USE; GOVERNMENT; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH CENTER; HUMAN; INJECTION; IRAN; MAJOR CLINICAL STUDY; PHARMACY; PHYSICIAN; PNEUMONIA; PRESCRIPTION; PRIMARY MEDICAL CARE; SALARY; UPPER RESPIRATORY TRACT INFECTION; WORLD HEALTH ORGANIZATION;

ANTI-BACTERIAL AGENTS; DRUG COSTS; DRUG STORAGE; DRUG UTILIZATION; DRUGS, ESSENTIAL; EFFICIENCY, ORGANIZATIONAL; GUIDELINE ADHERENCE; HEALTH CARE SURVEYS; HEALTH POLICY; HEALTH SERVICES ACCESSIBILITY; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; IRAN; NATIONAL HEALTH PROGRAMS; PHARMACIES; PHARMACOPOEIAS; PHYSICIAN'S PRACTICE PATTERNS; PNEUMONIA; PRACTICE GUIDELINES; PRESCRIPTIONS, DRUG; QUALITY INDICATORS, HEALTH CARE; SALARIES AND FRINGE BENEFITS;

EID: 26044472348     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Dinarvand R. Iran: an evolving national drug policy. Essential drug monitor, 1998, 22:9-10.
2. Operational package for monitoring and assessing country pharmaceutical situations. Geneva, World Health Organization, 2001. (http://www.who.int/medicines/strategy/policy/indicatorsop.shtml, accessed 19/09/04).
3. Pharmaceutical indicators and monitoring/assessment package, meeting 1-21 February 2003. Geneva, World Health Organization, 2003.
4. International drug price indicator guide. Boston, Massachusetts, Management Sciences for Health, 2001.
5. Nikfar S, Abdollahi M, Cheraghali A. Going from strength to strength - Iran's drug and poison information service. Essential drug monitor, 2000, 28/29:30-1.
6. Abdollahi M, Nikfar S. Three year report on Tehran Drug and Poison Information Centre. In: Proceedings of the VII World Conference on Clinical Pharmacology and Therapeutics, Division of Clinical Pharmacology, and 4th Congress of the European Association for Clinical Pharmacology and Therapeutics, Florence, Italy, 15- 20 July 2000:114.
7. van Staa A, Hardon A. Injection practices in the developing world. Results and recommendations from field studies in Uganda and Indonesia. Geneva, World Health Organization, 1996 (WHO/DAP/96.4).